Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
Dr Elena Portacolone joins Ethics Talk to discuss her article, coauthored with Daisy Elise Feddoes: “Should Artificial Intelligence Play a Role in Cultivating Social Connections Among Older Adults?”
High reliability organizations operate in complex, high-hazard domains for extended periods without serious accidents, catastrophic failures, or ecological health threats.
AMA J Ethics. 2024;26(2):E171-178. doi:
10.1001/amajethics.2024.171.
Lloyd Duplechan joins Ethics Talk to discuss his article: "How High Reliability Can Facilitate Clinical, Organizational, and Public Health Responses to Global Ecological Health Risks.”
Michael Toppe, DMSc, PA-C and Lushiku Nkombua, MD, MMed
American physician assistant students trained in South Africa to study an example of a reverse innovation practice that could be incorporated in the US.
AMA J Ethics. 2023;25(5):E332-337. doi:
10.1001/amajethics.2023.332.
Dr Esha Bansal joins Ethics Talk to discuss her article, coauthored with Drs Saran Kunaprayoon and Linda P. Zhang: “Opportunities for Global Health Diplomacy in Transnational Robotic Telesurgery.”